AU2011212564B2 — Medicated module with lockable needle guard
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2015-02-05 · 11y expired
What this patent protects
A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device (7) containing a primary medicament accepts a medicated module (4) containing a single dose of a secondary medicament and where both medicaments are …
USPTO Abstract
A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device (7) containing a primary medicament accepts a medicated module (4) containing a single dose of a secondary medicament and where both medicaments are delivered through a single hollow needle (3). The medicated module (4) is configured so that it will first deliver both the primary and secondary medicaments and then, if needed, a dose(s) of additional primary medicament. The module (4) also contains a needle guard (22) that locks the first dose delivery, but can be manually overridden by a user to perform a second or subsequent injection of primary medicament.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.